Home » Newsletters » BioWorld Science

BioWorld Science

July 2, 2003

View Archived Issues

Enrollment completed in phase II trial of SRP-299 for asthma

Thai phase IIa trial of DB-289 for malaria opens enrollment

Acapodene reduces high-grade prostate intraepithelial neoplasia in phase II study

Lexicon Genetics discover new target for cognitive disorders

Positive Japanese phase III data for Zadaxin in hepatitis B

Cypress Bioscience prepares for milnacipran trial in IBS

Phase I results for NBI-42902

Schering acquires license to Philogen's antibody-based therapeutic fusion protein

Manufacturing begins in preparation for EradicAide trial

Oxazole-based inducers of BDNF production and their use in diabetic neuropathy

New aciclovir prodrugs and their use in ocular viral infections

Roche researchers describe the preparation and use of novel cathepsin K inhibitors

New CRF antagonists in early development at Roche

Novel glucagon antagonists in Novo Nordisk development pipeline

Novartis patents new mGluR5 antagonists for anxiety, pain, etc.

Metabolic glutamate mGluR5 antagonists covered by Merck patent

New thrombin inhibitors prepared and tested by U. of Ljubljana and LEK researchers

Inhibition of alpha4beta1 as a new approach to multiple sclerosis

In vitro and in vivo profile of new orally active histamine H3 antagonist

CPMP hands down positive opinion for Avandamet

Clenoliximab enhances the efficacy of methotrexate in active rheumatoid arthritis

Comparison of the efficacy and safety profiles of etoricoxib and naproxen in rheumatoid arthritis

Inspire files first NDA for ocular therapy partnered with Allergan

Phase III ARISE trial of AGI-1067 opens enrollment

ABthrax cleared to enter clinical testing

Bexxar approved by FDA

Beneficial effects of pregabalin in healthy volunteers and patients with fibromyalgia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...